Abstract: Carbothioamides 4a,b, obtained from nalidixic acid, were converted to the corresponding 1,3-thiazolidine derivatives 5a,b by cyclocondensation with 2-bromo-1-(4-chlorophenyl)ethanone. Treatment of 4a,b with base afforded 1,2,4-triazoles 6a,b. The synthesis of 1,3-oxazolidine 7 was performed by the reaction of compound 4a with ethyl bromoacetate. Treatment of 4a with acid produced 1,3,4-thiadiazole 8. The reaction of compounds 6a and 6b with several heterocyclic amines in the presence of formaldehyde gave the corresponding Mannich bases 9-15 containing various pharmacophore groups. Conventional and microwave-assisted methods were used for the synthesis. The effect of an acid catalyst on Mannich reactions was investigated. The structures of the newly synthesized compounds were elucidated on the basis of 1 H NMR, 13 C NMR, FTIR, EIMS techniques, and elemental analysis. All compounds were screened for their antimicrobial activity.
Introduction
Nalidixic acid [1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, 1] was the first synthetic quinolone derivative introduced for the treatment of urinary tract infections in 1963 [1] . It inhibits DNA synthesis by promoting cleavage of bacterial DNA in the DNA-enzyme complexes of DNA gyrase, resulting in rapid bacterial death [2] . It is particularly effective against Gram-negative bacteria [3, 4] . Since the introduction of nalidixic acid for the treatment of bacterial infections, a number of derivatives have been synthesized. Among them, fluoroquinolones such as norfloxacin, pefloxacin, enoxacin, ofloxacin, and ciprofloxacin play a major role in the treatment of bacterial infections by displaying excellent pharmacokinetic properties, high antimicrobial activity, and low side effects [5] [6] [7] [8] [9] . Quinolones have been reported to have wide-ranging biological activities including antitubercular [10] , fungicidal [11] , antimalarial [12] , anticancer and anti-HIV [12] , antiviral [13] , and antibacterial [14] properties.
The considerable biological importance of triazoles has stimulated a lot of interest in their derivatives [15] . A large number of 1,2,4-triazoles exhibit antibacterial, antifungal, antitubercular, analgesic, antiinflammatory, anticancer, anticonvulsant, antiviral, insecticidal, antidepressant, and central nervous system-affecting activities. 1,2,4-Triazoles, by virtue of their ambident nucleophilic centers, are good starting materials for the synthesis of several interesting N-and S-bridged heterocycles. The triazoles can be converted to thiazolotriazoles, triazolothiadiazoles, triazolooxazolidines, and various Mannich bases [16] [17] [18] [19] [20] . In addition, a 1,3,4-thiadiazole system constitutes the active part of several biologically active compounds [21] [22] [23] [24] . A thiazolidinone ring is an attractive target for combinatorial synthesis as its structure-activity relationship belongs to an important class of N-and S-containing heterocycles, which are widely used in drug design and synthesis [25, 26] . Related oxazolidinones are also biologically active [27] [28] [29] [30] .
In this paper, we report the synthesis of new hybrid compounds which are derivatives of the systems mentioned above and possess an interesting profile of antimicrobial activity. The synthetic work was enhanced by using Mannich reaction [31] , homogeneous catalysis [32] , and eco-friendly microwave irradiation [33] .
Results and discussion

Chemistry
The main aim of this study was to synthesize antimicrobial hybrid molecules containing different heterocyclic moieties. The synthetic strategies adopted to obtain the target compounds are depicted in Schemes 1-3. The synthesis was achieved by using both microwave (eco-friendly) and conventional methods. The structures of all products were established on the basis of physicochemical, spectral, and elemental analysis data.
The esterification of nalidixic acid (1) with ethanol in the presence of a catalytic amount of sulfuric acid furnished ester 2. Then, compound 2 was converted to the acetohydrazide 3 by treatment with hydrazine hydrate.
Synthesis of 3 required 20-22 h of heating under reflux conditions and the yield was 75-78%. Under microwave irradiation at 100°C for 15 min, the yield was 88-98%. Compound 3 was converted to carbothioamides 4a,b by treatment with benzylisothiocyanate and ethylisothiocyanate, respectively (Scheme 1). Again, the use of microwave irradiation was superior to the conventional synthesis. Condensation of compounds 4a,b with 4-chlorophenacyl bromide in ethanolic solution furnished the corresponding thiazoles 5a,b (Scheme 2). Again, the microwave method was preferred. The remaining preparations shown in Schemes 2 and 3 also benefited from the use of the microwave irradiation methodology. Triazoles 6a,b were obtained by intramolecular cyclization of compounds 4a,b. The aim was to introduce the 1,2,4-triazole nucleus to the nalidixic acid skeleton because it is known that more efficacious antibacterial compounds can be designed by joining two biologically active components together into a single molecular framework [34] [35] [36] [37] [38] . The synthesis of carbohydrazide 7 was performed by the reaction of compound 4a with ethyl bromoacetate in ethanolic solution, while the cyclization of 4a in an acidic medium yielded a 1,3,4-thiadiazole 8.
Mannich bases are physiologically reactive agents [39] [40] [41] . Mannich bases 9-15 were obtained by treatment of compounds 6a,b with formaldehyde and several biologically active amines (Scheme 3) [6, 8, 34, 42, 43] . Three different methods were used for the Mannich reactions. These were a conventional method in the absence of a catalyst, a conventional method in the presence of a catalyst, and microwave irradiation-assisted synthesis. The classical heating in the absence of any catalyst furnished the desired products in low-yield after 24 h. The same products were obtained in the yields of 53-97% at room temperature after 5 h in the presence of InCl 3 or p-toluenesulfonic acid as a Brønsted-Lowry acid catalyst. In the microwave irradiation-assisted method the temperature was held constant at 50 o C, the reaction time was 5 min and the Mannich bases were obtained in yields of 43-99%. Thus, microwave irradiation provided more efficient and green way to Mannich products and a relatively higher yield.
Antimicrobial activity
All synthesized compounds were screened for their antimicrobial activity. Compounds 2, 3, 4a,b, 5a,b, 6a,b, 7 , and 8 are active against some of the test microorganisms with the minimal inhibition concentration (MIC) values in the range of 0.49-500 μg/mL (Table 1) . Compounds 4a,b and 6a,b are exceptionally active against Escherichia coli (E. coli), Gram-negative bacteria. Mannich bases 9-15 show good-to-moderate activity against some of the test microorganisms. Among these, compounds 11a,b with a β-lactam nucleus attached to nalidixic acid skeleton display remarkable antimicrobial activities against two Gram-positive bacteria. Compound 11a is active against Mycobacterium smegmatis (M. smegmatis), a nonpigmented rapidly growing mycobacterium with the MIC value < 1 μg/mL, which is better than that for standard drug streptomycin. Compound 11b is active against Enterococcus faecalis (E. faecalis), for which the MIC value of 6 μg/mL is better than that for the reference drug ampicillin. Exceptional activity can be observed for some other Mannich bases (Table 1) .
Conclusions
Several biologically active hybrid compounds containing a nalidixic acid moiety were obtained. The antimicrobial screening showed that compounds containing norfloxacine, ciprofloxacine or 7-aminocephalosporanic acid system display excellent antimicrobial activity. Several compounds are more active against E. coli and M. smegmatis than the reference drug ampicillin and streptomycin.
Experimental
All chemicals were purchased from Fluka Chemie AG (Buchs, Switzerland) and used without further purification. Melting points were determined in open capillaries on a Büchi B-540 melting point apparatus and are uncorrected. Reactions were monitored by thin layer chromatography (TLC) on silica gel using 60 F 254 aluminum sheets. The mobile phase was ethyl acetate/diethyl ether (1:1) and detection was under UV light. FT-IR spectra were recorded using a Perkin Elmer 1600 series FT-IR spectrometer. 
1-Ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide (3)
Method 1 A solution of compound 2 (2.60 g, 0.01 mol) and hydrazine hydrate (1.46 mL, 0.03 mol) in ethanol was heated under reflux for 20 h, then cooled and kept in the refrigerator for 12 h. The resultant solid was collected by filtration and crystallized from ethanol. 
General synthesis of compounds 4a,b
Method 1 To a solution of compound 3 (2.46 g, 0.01 mol) in dichloromethane, benzyl isothiocyanate (for 4a, 2.46 g, 0.01 mol) or ethyl isothiocyanate (for 4b, 1.75 g, 0.02 mol), was added and the mixture was stirred at room temperature for 24 h and then concentrated under reduced pressure. The residue was crystallized from ethanol (4a) or from dimethyl sulfoxide/water (1:3) (4b).
Method 2 A mixture of compound 3 (1 mmol) and the corresponding isothiocyanate (1 mmol) in ethanol was irradiated in a closed vessel with the pressure control at 100°C for 10 min. After cooling the mixture was poured into ice water and the resultant solid was crystallized from an appropriate solvent. 
N-Benzyl-2-[(1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-3-yl)carbonyl]hydrazinecarbothioamide (4a) Yield
General synthesis of compounds 5a,b
Method 1 4-Chlorophenacyl bromide (2.33 g, 0.01 mol) and sodium acetate (4.1 g, 0.05 mol) were added to the solution of compound 4a (3.95 g, 0.01 mol, for 5a) or compound 4b (3.33 g, 0.01 mol, for 5b) in ethanol and the mixture was heated under reflux for 54 h (for 5a) or 45 h (for 5b), as monitored by TLC. Then, the mixture was cooled to room temperature and concentrated under reduced pressure. The resultant solid was filtered, washed with water and crystallized from dimethyl sulfoxide/water (1:3).
Method 2 A solution of 4-chlorophenacyl bromide (1 mmol), sodium acetate (5 mmol), compound 4a (1 mmol) or compound 4b (1 mmol) in ethanol was microwave-irradiated in a closed vessel at 150°C for 15 min. After completion of the reaction, as monitored by TLC, the mixture was poured into ice water. The crude product was filtered and crystallized from dimethyl sulfoxide/water (1:3). -5-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene]-1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3 
N′-[3-Benzyl
General synthesis of compounds 6a,b
Method 1 A solution of carbothioamide 4a (3.95 g, 0.01 mol, for 6a) or 4b (3.33 g, 0.01 mol, for 6b) in ethanol/water (1:1) was heated under reflux in the presence of 2 N NaOH for 16 h (for 6a) or 14 h (for 6b) with the progress of the reaction monitored by TLC. Then, the solution was cooled to room temperature and acidified to pH 7 with 37% HCl. The precipitate formed was filtered off, washed with water, and crystallized from methanol (for 6a) or ethanol /water (1:3) (for 6b).
Method 2 A mixture of compound 4a or 4b (1 mmol) and 2N NaOH (2 mmol) in ethanol (10 mL) was microwave-irradiated in a closed vessel at 150°C for 4 min with the progress of the reaction monitored by TLC. Then the resulting solution was cooled to room temperature and acidified to pH 5 with 37% HCl. The precipitate formed was filtered off, washed with water, and crystallized from an appropriate solvent indicated above. -5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)-1-ethyl-7-methyl-1,8-naphthyridin-4(1H) -3-(4-ethyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl) Benzyl-5-thioxo-1,3-oxazolidin-2-ylidene]-1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine- 
3-(4-Benzyl
1-Ethyl
N′-[3-
3-carbohydrazide (7)
Method 1 Ethyl bromoacetate (1.28 mL, 0.01 mol) and sodium acetate (4.1 g, 0.05 mol) were added to the solution of compound 4a (3.95 g, 0.01 mol) in ethanol and the mixture was heated under reflux for 24 h. Then, the mixture was cooled to room temperature and concentrated under reduced pressure. The residue was filtered, washed with water, and crystallized from dimethyl sulfoxide/water (1:3).
Method 2 A mixture of compound 4a (1 mmol), ethyl bromoacetate (1 mmol) and sodium acetate (5 mmol) in ethanol was irradiated in a closed vessel at 150°C for 13 min with the progress of the reaction monitored by TLC. After the completion of the reaction, the mixture was poured into ice water and the resultant precipitate was filtered and crystallized from dimethyl sulfoxide/water (1:3).
Yield 55% (method 1); yield 76% (method 2); mp 230-232°C; IR (υ max , cm 
3-[5-(Benzylamino)-4,5-dihydro-1,3,4-thiadiazol-2-yl]-1-ethyl-7-methyl-1,8-naphthyridin-4(1H)-one (8)
Method 1 A solution of carbothioamide 4a (3.95 g, 0.01 mol) in concentrated sulfuric acid (11 mL, 0.20 mol) was stirred for 15 min at 0°C, then allowed to reach room temperature and stirred for an additional 3 h. The solution was poured into ice-cold water and made alkaline to pH 7 with ammonia. The precipitated product was filtered, washed with water, and crystallized from ethanol/water (1:3).
Method 2 A solution of compound 4a (1 mmol) in concentrated sulfuric acid (1.5 mL) was irradiated in a closed vessel at 50°C for 4 min with the progress of the reaction monitored by TLC. After completion of the reaction, the mixture was poured into ice water and the resultant crude product was collected by filtration and crystallized from ethanol/water (1:3).
Yield 9-13 (a,b) Method 1 To a solution of compound 6a or 6b (0,01 mol) in dimethyl sulfoxide (10 mL), morpholine (for 9a and 9b, 0.87 mL, 0.01 mol) or thiomorpholine (for 10a and 10b, 0.94 mL, 0.01 mol) or 7-aminocephalosporanic acid (for 11a and 11b, 2.72 g, 0.01 mol) or norfloxacin (for 12a and 12b, 3.19 g, 0.01 mol) or ciprofloxacin (for 13a and 13b,  3.31 g, 0.01 mol) was added in the presence of formaldehyde (37%, 3.72 mL, 0.05 mol) and the mixture was stirred at room temperature for 22 h. The solution was poured into ice-cold water and the resultant solid was crystallized from ethanol/water (1:3) (for 9a,b, 10a,b) , from ethyl acetate (for 11a,b) and from dimethyl sulfoxide/water (1:3) (for 12a,b, 13a,b) .
General synthesis of compounds
Method 2 To a solution of compound 6a,b (1 mmol) in dimethyl sulfoxide (10 mL), morpholine (for 9a and 9b, 1 mmol) or thiomorpholine (for 10a and 10b, 1 mmol) or 7-aminocephalosporanic acid (for 11a and 11b, 1 mmol) or norfloxacin (for 12a and 12b, 1 mmol) or ciprofloxacin (for 13a and 13b, 1 mmol) was added in the presence of formaldehyde (5 mmol) and the mixture was stirred at room temperature for 15 min. Then, a catalytic amount of a suitable catalyst (InCl 3 or p-TsOH) was added and the stirring was continued for an additional 5 h. The mixture was poured into ice water and a resultant solid was crystallized from an appropriate solvent indicated above.
Method 3
The mixture, obtained as described above for method 2, was irradiated at 50°C in a microwave oven for 5 min with the progress of the reaction monitored by TLC. After cooling the solution was poured into ice water and the resultant precipitate was filtered off and crystallized from an appropriate solvent indicated above. 1H-1,2,4-triazol-3-yl]-1-ethyl-7-methyl-1,8-naphthyridin-4(1H) -3-[4-ethyl-1-(morpholin-4-ylmethyl)-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]-7-methyl-1,8-naphthyridin-4(1H) -1-(thiomorpholin-4-ylmethyl)-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]-1-ethyl-7-methyl-1,8-naphthyridin 27 (s, 2H), 6.45 (brs, 1H), 7.00-7.95 (m, 7H), 8.51 (s, 1H) Ethyl-3-[4-ethyl-1-(thiomorpholin-4-ylmethyl)-5-thioxo-4,5-dihydro-1H-1,2,4 -triazol-3-yl]-7-methyl-1,8-naphthyridin-4(1H) 4-benzyl-3-(1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-3-yl)-5-thioxo-4,5-dihydro-1H-1,2,4 4-ethyl-3-(1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-3-yl)-5-thioxo-4,5-dihydro-1H-1,2,4 {[4-ethyl-3-(1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-3-yl)-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-1-yl 
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General synthesis of compounds 14 and 15
Method 1 To a solution of compound 6a (0.01 mol) in dimethyl sulfoxide, 1-phenylpiperazine (for 14, 1.52 mL, 0.01 mol) or tryptamine (for 15, 1.60 g, 0.01 mol) was added in the presence of formaldehyde (37%, 3.72 mL, 0.05 mol) and the mixture was stirred at room temperature for 24 h, then poured into ice-cold water. The resultant precipitate was crystallized from ethanol/water (1:3).
Method 2 To a solution of compound 6a (1 mmol) in dimethyl sulfoxide, 1-phenylpiperazine (for 14, 1 mmol) or tryptamine (for 15, 1 mmol) was added in the presence of formaldehyde (5 mmol) and the mixture was stirred at room temperature for 15 min. Then, a catalytic amount of a catalyst (InCl 3 or p-TsOH) was added and the stirring was continued for an additional 5 h. The mixture was poured into ice water and the resultant precipitate was crystallized from ethanol/water (1:3).
Method 3 A solution, prepared as described above, was irradiated at 50 o C in the microwave oven for 5 min, then cooled to room temperature and poured into ice water. The resultant precipitate was filtered off and crystallized from ethanol/water (1:3). Benzyl-1-[(4-phenylpiperazin-1-yl)methyl]-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}-1-ethyl-7-methyl-1,8-naphthyridin 
3-{4-
Antimicrobial activity
The following test microorganisms were obtained from the Hifzissihha Institute of Refik Saydam (Ankara, Turkey): E. coli ATCC35218, Yersinia pseudotuberculosis (Y. pseudotuberculosis) ATCC911, Pseudomonas aeruginosa (P. aeruginosa) ATCC43288, E. faecalis ATCC29212, Staphylococcus aureus (S. aureus) ATCC25923, Bacillus cereus (B. cereus) 709 Roma, M. smegmatis ATCC607, Candida albicans (C. albicans) ATCC60193, and Saccharomyces cerevisiae (S. cerevisia) RSKK 251. All synthesized compounds were weighed and dissolved in hexane to prepare a stock solution of 20.0 μg/mL. The antimicrobial effects of the substances were tested quantitatively by using double microdilution; the MIC values (μg/mL) were determined. The antibacterial and antifungal assays were performed in Mueller-Hinton broth (MH) (Difco, Detroit, MI, USA) at pH 7.3 and buffered yeast nitrogen base (Difco, Detroit, MI, USA) at pH 7.0, respectively. The microdilution test plates were incubated for 18-24 h at 35°C. Brain heart infusion broth (BHI) (Difco, Detriot, MI, USA) was used for M. smegmatis; incubation was for 48-72 h at 35°C [44] . Ampicillin, streptomycin, and fluconazole were used as standard antibacterial and antifungal drugs. Dimethyl sulfoxide with a dilution of 1:10 was used as a solvent control.
